These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29496648)

  • 1. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
    Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
    Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.
    Mantripragada KC; Hamid F; Shafqat H; Olszewski AJ
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27707843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
    Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.
    Toge K; Sakata J; Hirose Y; Yuza K; Ando T; Soma D; Katada T; Miura K; Takizawa K; Kobayashi T; Wakai T
    Eur J Surg Oncol; 2019 Aug; 45(8):1446-1452. PubMed ID: 30962045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal assessment of lymph node status in gallbladder cancer.
    Kim SH; Chong JU; Lim JH; Choi GH; Kang CM; Choi JS; Lee WJ; Kim KS
    Eur J Surg Oncol; 2016 Feb; 42(2):205-10. PubMed ID: 26614023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy.
    Kasumova GG; Tabatabaie O; Najarian RM; Callery MP; Ng SC; Bullock AJ; Fisher RA; Tseng JF
    Ann Surg; 2017 Oct; 266(4):625-631. PubMed ID: 28692469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.
    Foster JM; Hoshi H; Gibbs JF; Iyer R; Javle M; Chu Q; Kuvshinoff B
    Ann Surg Oncol; 2007 Feb; 14(2):833-40. PubMed ID: 17103074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis of T1 and T2 stage gallbladder cancer with invasion within the gallbladder wall].
    Hou CS; Xu Z; Zhang TL; Peng Y; Ling XF; Wang LX; Zhou XS
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1620-3. PubMed ID: 17359693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection?
    Sakata J; Kobayashi T; Ohashi T; Hirose Y; Takano K; Takizawa K; Miura K; Ishikawa H; Toge K; Yuza K; Soma D; Ando T; Wakai T
    Eur J Surg Oncol; 2017 Apr; 43(4):780-787. PubMed ID: 28132788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy Use for Patients With Inadequately Resected T1b-T3 Gallbladder Cancer.
    White MJ; Prathibha S; Gupta A; Prakash A; Ankeny JS; LaRocca CJ; Hui JYC; Tuttle TM; Brauer D; Marmor S; Jensen EH
    J Surg Res; 2024 Oct; 302():293-301. PubMed ID: 39116829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
    Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
    J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
    He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
    World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical resection improves survival for patients with pT2 gallbladder carcinoma.
    Wise PE; Shi YY; Washington MK; Chapman WC; Wright JK; Sharp KW; Pinson CW
    Am Surg; 2001 Nov; 67(11):1041-7. PubMed ID: 11730220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
    Itoh H; Nishijima K; Kurosaka Y; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Saitoh Y
    Dig Dis Sci; 2005 Dec; 50(12):2231-42. PubMed ID: 16416167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
    Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
    Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
    Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.